Price T Rowe Associates Inc Icosavax, Inc. Transaction History

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$5.7 - $10.33 $8.59 Million - $15.6 Million
1,506,613 Added 82.07%
3,342,470 $19.2 Million
Q1 2022

May 16, 2022
BUY
$4.41 - $22.5 $1.05 Million - $5.34 Million
237,305 Added 14.84%
1,835,857 $12.9 Million
Q4 2021

Feb 14, 2022
BUY
$21.07 - $34.98 $5.19 Million - $8.62 Million
246,423 Added 18.22%
1,598,552 $36.6 Million
Q3 2021

Nov 15, 2021
BUY
$24.85 - $40.25 $33.6 Million - $54.4 Million
1,352,129 New
1,352,129 $40 Million

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email